source
- Basecamp Research secures $140 million Series C to accelerate AI-designed drug pipelineBasecamp Research announced closing a $140 million Series C financing round to further develop its AI-driven drug discovery platform. The round was led by venture firm S32 and included participati…
- Gilead pushes further into immunology, touts inflammation drug pipelineGilead Sciences’ senior leadership has repeatedly emphasized the company’s long‑term ambition to expand beyond its virology roots into the inflammatory and autoimmune space. The messaging, delivere…